
Tute Genomics is a cloud-based clinical genome interpretation platform that enables researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment. It has developed the most advanced analytical methods for genome analysis by incorporating proprietary machine-learning algorithms into a cloud-based application that allows researchers to analyze and interpret entire human genomes and discover genes and biomarkers at an unprecedented rate. It was founded in 2012 and headquartered in Provo, Utah.

Tute Genomics is a cloud-based clinical genome interpretation platform that enables researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment. It has developed the most advanced analytical methods for genome analysis by incorporating proprietary machine-learning algorithms into a cloud-based application that allows researchers to analyze and interpret entire human genomes and discover genes and biomarkers at an unprecedented rate. It was founded in 2012 and headquartered in Provo, Utah.
What they do: Cloud-based clinical genome interpretation and annotation platform
Founded / HQ: 2012, Provo, Utah
Exit: Acquired by PierianDx (October 2016)
Notable investors: Tencent; Healthbox; others reported
Last disclosed funding: Series A, June 16, 2015
Clinical genome interpretation, genomic analysis and annotation for research and clinical use
2012
Genomics / Healthtech
Reported as the last disclosed round (June 16, 2015)
“Investors reported include Tencent and Healthbox (among others)”